Loading...
Header Logo
Keywords
Last Name
Institution

Camille C Gunderson

TitleProf,Asst
InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentObstetrics and Gynecology
Address800 NE 10th St
Oklahoma City OK 73104-0001
Phone405/271-8707
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    Louisiana State University, New Orleans, LAMD2008Medicine
    University of Oklahoma, Oklahoma City, OKMS2016Clinical and Translational Research

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Buechel M, McGinnis A, Vesely SK, Wade KS, Moore KN, Gunderson CC. Consideration of older patients for enrollment in phase 1 clinical trials: Exploring treatment related toxicities and outcomes. Gynecol Oncol. 2018 04; 149(1):28-32. PMID: 29605046.
      View in: PubMed
    2. Temkin SM, Rimel BJ, Bruegl AS, Gunderson CC, Beavis AL, Doll KM. A contemporary framework of health equity applied to gynecologic cancer care: A Society of Gynecologic Oncology evidenced-based review. Gynecol Oncol. 2018 04; 149(1):70-77. PMID: 29605053.
      View in: PubMed
    3. Gunderson CC, Matulonis U, Moore KN. Management of the toxicities of common targeted therapeutics for gynecologic cancers. Gynecol Oncol. 2018 03; 148(3):591-600. PMID: 29395304.
      View in: PubMed
    4. Greenwade MM, Moore KN, Gillen JM, Ding K, Rowland MR, Crim AK, Kleis B, Gunderson CC. Factors influencing clinical trial enrollment among ovarian cancer patients. Gynecol Oncol. 2017 09; 146(3):465-469. PMID: 28689668.
      View in: PubMed
    5. Danala G, Thai T, Gunderson CC, Moxley KM, Moore K, Mannel RS, Liu H, Zheng B, Qiu Y. Applying Quantitative CT Image Feature Analysis to Predict Response of Ovarian Cancer Patients to Chemotherapy. Acad Radiol. 2017 10; 24(10):1233-1239. PMID: 28554551.
      View in: PubMed
    6. Gillen J, Gunderson C, Greenwade M, Rowland M, Ruskin R, Ding K, Crim A, Walter A, White E, Moore K. Contribution of age to clinical trial enrollment and tolerance with ovarian cancer. Gynecol Oncol. 2017 04; 145(1):32-36. PMID: 28087143.
      View in: PubMed
    7. Prendergast EN, Holzapfel M, Mueller JJ, Leitao MM, Gunderson CC, Moore KN, Erickson BK, Leath CA, Diaz Moore ES, Cohen JG, Walsh CS. Three versus six cycles of adjuvant platinum-based chemotherapy in early stage clear cell ovarian carcinoma - A multi-institutional cohort. Gynecol Oncol. 2017 Feb; 144(2):274-278. PMID: 27979319.
      View in: PubMed
    8. Fader AN, Java J, Tenney M, Ricci S, Gunderson CC, Temkin SM, Spirtos N, Kushnir CL, Pearl ML, Zivanovic O, Tewari KS, O'Malley D, Hartenbach EM, Hamilton CA, Gould NS, Mannel RS, Rodgers W, Walker JL. Impact of histology and surgical approach on survival among women with early-stage, high-grade uterine cancer: An NRG Oncology/Gynecologic Oncology Group ancillary analysis. Gynecol Oncol. 2016 Dec; 143(3):460-465. PMID: 27743738.
      View in: PubMed
    9. Gunderson CC, Ding K, Dvorak J, Moore KN, McMeekin DS, Benbrook DM. The pro-inflammatory effect of obesity on high grade serous ovarian cancer. Gynecol Oncol. 2016 10; 143(1):40-45. PMID: 27423378.
      View in: PubMed
    10. Gunderson CC, Walter AC, Ruskin R, Ding K, Moore KN. Post-intensive care unit syndrome in gynecologic oncology patients. Support Care Cancer. 2016 11; 24(11):4627-32. PMID: 27306212.
      View in: PubMed
    11. Gunderson CC, Parsons B, Penaroza S, Peyton MD, Landrum LM. Intravenous leiomyomatosis disguised as a large deep vein thrombosis. J Radiol Case Rep. 2016 May; 10(5):29-35. PMID: 27761178.
      View in: PubMed
    12. Slaughter K, Holman LL, Thomas EL, Gunderson CC, Lauer JK, Ding K, McMeekin DS, Moore KM. Primary and acquired platinum-resistance among women with high grade serous ovarian cancer. Gynecol Oncol. 2016 08; 142(2):225-30. PMID: 27208536.
      View in: PubMed
    13. Gunderson CC, Rowland MR, Wright DL, Andrade KL, Mannel RS, McMeekin DS, Moore KN. Initiation of a formalized precision medicine program in gynecologic oncology. Gynecol Oncol. 2016 Apr; 141(1):24-8. PMID: 27016225.
      View in: PubMed
    14. Mueller JJ, Holzapfel M, Han CH, Santos K, Gunderson C, Moore K, Erickson B, Leath CA, Diaz E, Walsh C, Wethington SL, Dejbakhsh SZ, Barakat RR, Gardner GJ, Hyman DM, Soslow RA, Leitao MM. Staging Lymphadenectomy in Patients With Clear Cell Carcinoma of the Ovary. Int J Gynecol Cancer. 2016 Jan; 26(1):120-4. PMID: 26509849.
      View in: PubMed
    15. Levinson KL, Jernigan AM, Flocke SA, Tergas AI, Gunderson CC, Huh WK, Wilkinson-Ryan I, Lawson PJ, Fader AN, Belinson JL. Intimate Partner Violence and Barriers to Cervical Cancer Screening: A Gynecologic Oncology Fellow Research Network Study. J Low Genit Tract Dis. 2016 Jan; 20(1):47-51. PMID: 26704329; PMCID: PMC4693628 [Available on 01/01/17].
    16. Gunderson CC, Moore KN. BRACAnalysis CDx as a companion diagnostic tool for Lynparza. Expert Rev Mol Diagn. 2015; 15(9):1111-6. PMID: 26292709.
      View in: PubMed
    17. Gunderson CC, Boyd J, O'Malley DM. Highlights from the Society of Gynecologic Oncology 2015 Annual Meeting on Women's Cancer. Gynecol Oncol. 2015 Jul; 138(1):3-6. PMID: 26269805.
      View in: PubMed
    18. Walter AC, Gunderson CC, Vesely SK, Algan O, Sughrue M, Slaughter KN, Moore KN. Central nervous system metastasis in gynecologic cancer: symptom management, prognosis and palliative management strategies. Gynecol Oncol. 2015 Mar; 136(3):472-7. PMID: 25752572.
      View in: PubMed
    19. Gunderson CC, Moore KN. Olaparib: an oral PARP-1 and PARP-2 inhibitor with promising activity in ovarian cancer. Future Oncol. 2015; 11(5):747-57. PMID: 25757679.
      View in: PubMed
    20. Gunderson CC, Moore KN. PARP inhibition in ovarian cancer: state of the science. Gynecol Oncol. 2015 Jan; 136(1):8-10. PMID: 25554012.
      View in: PubMed
    21. Gunderson CC, Thomas ED, Slaughter KN, Farrell R, Ding K, Farris RE, Lauer JK, Perry LJ, McMeekin DS, Moore KN. The survival detriment of venous thromboembolism with epithelial ovarian cancer. Gynecol Oncol. 2014 Jul; 134(1):73-7. PMID: 24793732.
      View in: PubMed
    22. Gunderson CC, Java J, Moore KN, Walker JL. The impact of obesity on surgical staging, complications, and survival with uterine cancer: a Gynecologic Oncology Group LAP2 ancillary data study. Gynecol Oncol. 2014 Apr; 133(1):23-7. PMID: 24680587.
      View in: PubMed
    23. Gunderson CC, Dutta S, Fader AN, Maniar KP, Nasseri-Nik N, Bristow RE, Diaz-Montes TP, Palermo R, Kurman RJ. Pathologic features associated with resolution of complex atypical hyperplasia and grade 1 endometrial adenocarcinoma after progestin therapy. Gynecol Oncol. 2014 Jan; 132(1):33-7. PMID: 24316307.
      View in: PubMed
    24. Gunderson CC, Nugent EK, Yunker AC, Rocconi RP, Graybill WS, Erickson BK, Moore KN. Vaginal cancer: the experience from 2 large academic centers during a 15-year period. J Low Genit Tract Dis. 2013 Oct; 17(4):409-13. PMID: 23609592.
      View in: PubMed
    25. Gunderson CC, Tergas AI, Fleury AC, Diaz-Montes TP, Giuntoli RL. Primary uterine cancer in Maryland: impact of distance on access to surgical care at high-volume hospitals. Int J Gynecol Cancer. 2013 Sep; 23(7):1244-51. PMID: 23899587.
      View in: PubMed
    26. Gunderson CC, Nugent EK, McMeekin DS, Moore KN. Distance traveled for treatment of cervical cancer: who travels the farthest, and does it impact outcome? Int J Gynecol Cancer. 2013 Jul; 23(6):1099-103. PMID: 23765207.
      View in: PubMed
    27. Gunderson CC, Farrell R, Dinh BC, Thomas ED, Vesely SK, Lauer JK, Kao L, Chopra S, McMeekin DS, Moore KN. Inpatient versus outpatient management of neutropenic fever in gynecologic oncology patients: is risk stratification useful? Gynecol Oncol. 2013 Sep; 130(3):411-5. PMID: 23791827.
      View in: PubMed
    28. Gunderson CC, Nugent EK, Elfrink SH, Gold MA, Moore KN. A contemporary analysis of epidemiology and management of vaginal intraepithelial neoplasia. Am J Obstet Gynecol. 2013 May; 208(5):410.e1-6. PMID: 23380265.
      View in: PubMed
    29. Gunderson CC, Fader AN, Carson KA, Bristow RE. Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review. Gynecol Oncol. 2012 May; 125(2):477-82. PMID: 22245711.
      View in: PubMed
    30. Gunderson CC, Knight J, Ybanez-Morano J, Ritter C, Escobar PF, Ibeanu O, Grumbine FC, Bedaiwy MA, Hurd WW, Fader AN. The risk of umbilical hernia and other complications with laparoendoscopic single-site surgery. J Minim Invasive Gynecol. 2012 Jan-Feb; 19(1):40-5. PMID: 22033285.
      View in: PubMed
    31. Ghomi A, Cohen SL, Chavan N, Gunderson C, Einarsson J. Laparoscopic-assisted vaginal hysterectomy vs laparoscopic supracervical hysterectomy for treatment of nonprolapsed uterus. J Minim Invasive Gynecol. 2011 Mar-Apr; 18(2):205-10. PMID: 21354066.
      View in: PubMed
    32. Fader AN, Levinson KL, Gunderson CC, Winder AD, Escobar PF. Laparoendoscopic single-site surgery in gynaecology: A new frontier in minimally invasive surgery. J Minim Access Surg. 2011 Jan; 7(1):71-7. PMID: 21197247; PMCID: PMC3002012.
    33. Fader AN, Cohen S, Escobar PF, Gunderson C. Laparoendoscopic single-site surgery in gynecology. Curr Opin Obstet Gynecol. 2010 Aug; 22(4):331-8. PMID: 20592589.
      View in: PubMed
    34. Gunderson CC, Gupta MR, Lopez F, Lombard GA, LaPlace SG, Taylor DE, Dhillon GS, Valentine VG. Clostridium difficile colitis in lung transplantation. Transpl Infect Dis. 2008 Jul; 10(4):245-51. PMID: 18312477.
      View in: PubMed
    Gunderson's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _